Yaron Daniely is a General Partner, where he co-leads Velocity, an early-stage investment fund pursuing disruptive, cutting-edge technologies with the potential to accelerate cure.
Born in Israel and raised in Florida, Yaron was fascinated by science, medicine, and technology from a young age. Driven by a passion for discovering and creating novel solutions, and a persistent quest for challenging the status quo wherever he went, Yaron spent much of his career leading innovative HealthTech companies. He brings to aMoon a wealth of hands-on experience as a business leader in both the private and public sectors. In return, aMoon fulfills his craving for cutting-edge science and strategic thinking, applied to the creation and mentorship of young companies focused on impacting people’s health.
Prior to aMoon, Yaron was the President and CEO of Yissum, Hebrew University’s acclaimed Technology Transfer Company, and Co-Chairperson of the Israel Technology Transfer Network (ITTN), where he converted academic research into practical projects and technologies. Before leading Yissum, he spent 14 years as a senior executive - and 10 years as CEO - of private and NASDAQ-traded Biopharma and Biotech companies. He also co-founded and served as the director of Israel's first and leading MBA program for professionals in the local Biomedical industry at the College of Management Academic Studies for 10 years.
Yaron earned his PhD from the Sackler Institute of Graduate Biomedical Sciences at the NYU School of Medicine. Following his doctoral program, he served as a Visiting Fellow at the NIH, and as an American Cancer Society Postdoctoral Fellow in the Department of Molecular Cell Biology at The Weizmann Institute for Science in Israel. He also holds an MBA from the Technion - Israel Institute of Technology.
